Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer-Reference-Cited by-同舟云学术

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

Published:2003 Issue:8 Volume:5 Page:690-699
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:J. Gene Med.

Author:

Rochlitz Christoph,Figlin Robert,Squiban Patrick,Salzberg Marc,Pless Miklos,Herrmann Richard,Tartour Eric,Zhao Yongxiang,Bizouarne Nadine,Baudin Martine,Acres Bruce

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Reference48 articles.

1. Monoclonal Antibodies Reactive with the Breast Carcinoma-Associated Mucin Core Protein Repeat Sequence Peptide Also Recognise the Ovarian Carcinoma-Associated Sebaceous Gland Antigen

2. A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen. cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue

3. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2;Vaccines;2024-05-02

2. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges;Frontiers in Immunology;2024-04-09

3. Vaccines and Oncolytic Virus for the Treatment of Lung Cancer;Immunotherapy Against Lung Cancer;2024

4. A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases;eBioMedicine;2023-04

5. Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention;Cancer Prevention Research;2023-03-31